Cristofanilli M - Search Results

1

Systemic treatments for inflammatory breast cancer.

Yang CH, Cristofanilli M. Yang CH, et al. Among authors: cristofanilli m. Breast Dis. 2005-2006;22:55-65. doi: 10.3233/bd-2006-22107. Breast Dis. 2005. PMID: 16735787 Review.

2

Current methods to prevent the development of breast cancer.

Cristofanilli M, Hortobagyi GN. Cristofanilli M, et al. In Vivo. 1998 Nov-Dec;12(6):659-65. In Vivo. 1998. PMID: 9891229 Review.

3

Phase I/II trial of high dose mitoxantrone in metastatic breast cancer: the M.D. Anderson Cancer Center experience.

Cristofanilli M, Holmes FA, Esparza L, Valero V, Buzdar AU, Neidhart JA, Hortobagyi GN. Cristofanilli M, et al. Breast Cancer Res Treat. 1999 Apr;54(3):225-33. doi: 10.1023/a:1006104610727. Breast Cancer Res Treat. 1999. PMID: 10445421 Clinical Trial.

4

Chemo-signal therapy, an emerging new approach to modify drug resistance in breast cancer.

Pusztai L, Esteva FJ, Cristofanilli M, Hung MC, Hortobagyi GN. Pusztai L, et al. Among authors: cristofanilli m. Cancer Treat Rev. 1999 Oct;25(5):271-7. doi: 10.1053/ctrv.1999.0132. Cancer Treat Rev. 1999. PMID: 10544071 Review.

5

Primary inflammatory carcinoma of the breast: retrospective review of mammographic findings.

Kushwaha AC, Whitman GJ, Stelling CB, Cristofanilli M, Buzdar AU. Kushwaha AC, et al. Among authors: cristofanilli m. AJR Am J Roentgenol. 2000 Feb;174(2):535-8. doi: 10.2214/ajr.174.2.1740535. AJR Am J Roentgenol. 2000. PMID: 10658737

6

Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy.

Buchholz TA, Tucker SL, Erwin J, Mathur D, Strom EA, McNeese MD, Hortobagyi GN, Cristofanilli M, Esteva FJ, Newman L, Singletary SE, Buzdar AU, Hunt KK. Buchholz TA, et al. Among authors: cristofanilli m. J Clin Oncol. 2001 Apr 15;19(8):2240-6. doi: 10.1200/JCO.2001.19.8.2240. J Clin Oncol. 2001. PMID: 11304777

7

Paclitaxel in the multimodality treatment for inflammatory breast carcinoma.

Cristofanilli M, Buzdar AU, Sneige N, Smith T, Wasaff B, Ibrahim N, Booser D, Rivera E, Murray JL, Valero V, Ueno N, Singletary ES, Hunt K, Strom E, McNeese M, Stelling C, Hortobagyi GN. Cristofanilli M, et al. Cancer. 2001 Oct 1;92(7):1775-82. doi: 10.1002/1097-0142(20011001)92:7<1775::aid-cncr1693>3.0.co;2-e. Cancer. 2001. PMID: 11745249 Clinical Trial.

8

New horizons in treating metastatic disease.

Cristofanilli M, Hortobagyi GN. Cristofanilli M, et al. Clin Breast Cancer. 2001 Jan;1(4):276-87. doi: 10.3816/CBC.2001.n.002. Clin Breast Cancer. 2001. PMID: 11899350 Review.

9

Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer.

Esteva FJ, Valero V, Booser D, Guerra LT, Murray JL, Pusztai L, Cristofanilli M, Arun B, Esmaeli B, Fritsche HA, Sneige N, Smith TL, Hortobagyi GN. Esteva FJ, et al. Among authors: cristofanilli m. J Clin Oncol. 2002 Apr 1;20(7):1800-8. doi: 10.1200/JCO.2002.07.058. J Clin Oncol. 2002. PMID: 11919237 Clinical Trial.

10

Molecular prognostic factors for breast cancer metastasis and survival.

Esteva FJ, Sahin AA, Cristofanilli M, Arun B, Hortobagyi GN. Esteva FJ, et al. Among authors: cristofanilli m. Semin Radiat Oncol. 2002 Oct;12(4):319-28. doi: 10.1053/srao.2002.35251. Semin Radiat Oncol. 2002. PMID: 12382190 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

464 results

Search Page

Filters